Environmental levels of the brominated flame retardant (BFR) hexabromocyclododecane (HBCD) have been increasing. HBCD has been shown to cause adverse effects on learning and behavior in mice, as well as on dopamine uptake in rat synaptosomes and synaptic vesicles. For other BFRs, alterations in the intracellular Ca 21 homeostasis have been observed. Therefore, the aim of this study was to investigate whether the technical HBCD mixture and individual stereoisomers affect the intracellular Ca 21 concentration ([Ca 21 ] i ) in a neuroendocrine in vitro model (PC12 cells). [Ca 21 ] i and vesicular catecholamine release were measured using respectively single-cell Fura-2 imaging and amperometry. Exposure of PC12 cells to the technical HBCD mixture or individual stereoisomers did neither affect basal [Ca 21 ] i , nor the frequency of basal neurotransmitter release. However, exposure to HBCD (0-20mM) did cause a dose-dependent reduction of a subsequent depolarization-evoked increase in [Ca 21 ] i . This effect was apparent only when HBCD was applied at least 5 min before depolarization (maximum effect after 20 min exposure). The effects of a-and b-HBCD were comparable to that of the technical mixture, whereas the inhibitory effect of g-HBCD was larger. Using specific blockers of L-, N-or P/Q-type voltage-gated Ca 21 channels (VGCCs) it was shown that the inhibitory effect of HBCD is not VGCC-specific. Additionally, the number of cells showing depolarization-evoked neurotransmitter release was markedly reduced following HBCD exposure. Summarizing, HBCD inhibits depolarization-evoked [Ca 21 ] i and neurotransmitter release. As increasing HBCD levels should be anticipated, these findings justify additional efforts to establish an adequate exposure, hazard and risk assessment.
Brominated flame retardants (BFRs) are a structurally diverse class of compounds added to consumer products for fire prevention. Increasing concentrations of these compounds in the environment, human food chain and in human tissues raise concern about possible neurotoxic effects, particularly for the developing nervous system (for review, Costa and Giordano, 2007) . This concern has led to voluntary action and legislative measures to eliminate the penta-and octabrominated diphenyl ethers from the market in Europe and North America. After cessation of their use in consumer products, a sharp rise in environmental levels of the BFR hexabromocyclododecane (HBCD) was recently observed (for review, Law et al., 2008) . This is possibly due to an increased use of HBCD as a replacement of the banned polybrominated diphenyl ethers (PBDEs), mainly in polystyrene products. The technical mixture of HBCD consists of three stereoisomers, denoted a-, b-, and c-HBCD. HBCD has been shown to biomagnify in marine food chains (Jenssen et al., 2007) . Interestingly, biotic samples are in general dominated by the a-stereoisomer although the technical mixture consists for 70-90% of c-HBCD (Covaci et al., 2006) . This is probably due to isomer composition changes during heating of the technical mixture during industrial application (Heeb et al., 2008) , and/or cytochrome P450 mediated biotransformation of b-and c-HBCD in biota (Zegers et al., 2005) .
Acute in vivo toxicity of HBCD appears limited (Darnerud, 2003) . So far, studies on the toxic potential of HBCD have mainly focused on endocrine disruption. Adverse effects of HBCD on the steroid and thyroid hormone system as well as antagonistic effects on the androgen, progesterone and aryl hydrocarbon receptors have been described (Ema et al., 2008; Hamers et al., 2006; Palace et al., 2008; van der Ven et al., 2006) . Additionally, effects on hepatic gene expression and hepatic enzymes have been observed (Canton et al., 2008; Germer et al., 2006; Ronisz et al., 2004; Zhang et al., 2008b) .
Although an adverse effect on learning and behavior in mice (1.4 lmol/kg bw HBCD; Eriksson et al., 2006) , as well as on oxidative stress and the cellular antioxidant defense systems in fish brain (28 days exposure to 500 lg/l HBCD; Zhang et al., 2008b) have been observed, in vitro neurotoxicity data on HBCD are limited. So far, only inhibition of dopamine uptake in rat synaptosomes (IC 50 : 4lM) and synaptic vesicles (IC 50 : 3lM; Mariussen and Fonnum, 2003) and necrotic cell death in cerebellar granule cells after 24 h exposure (LC 50 : 3lM; Reistad et al., 2006) have been reported.
Alterations in the intracellular Ca 2þ homeostasis, as observed for PBDEs and ortho-substituted (noncoplanar) polychlorinated biphenyls (ortho-PCBs) (for review: Mariussen and Fonnum, 2006) , may play a role in the observed cytotoxicity and oxidative stress (Orrenius et al., 2003) . In neuronal cell-types, the main influx route of Ca 2þ is via voltagegated Ca 2þ channels (VGCCs). VGCCs are located in the cell membrane and open when the membrane depolarizes. The subsequent rapid influx of Ca 2þ can trigger various intracellular processes including neurotransmitter release (Barclay et al., 2005; Clapham, 2007) . Therefore, the aim of this study was to investigate the possible effects of the technical HBCD mixture and the individual HBCD stereoisomers on basal and depolarization-evoked cytosolic Ca 2þ levels as well as on vesicular catecholamine release in a neuroendocrine in vitro model (PC12 cells), using respectively Fura-2 imaging and amperometry.
MATERIALS AND METHODS
Chemicals. The technical HBCD mixture was synthesized and the stereoisomers a-, b-, and c-HBCD isolated and purified (~99%) at the Stockholm University (Sweden) as described previously (Fång, 2007) . Unless otherwise noted, PC12 cells were exposed to the technical HBCD mixture. Before dilution to the desired final concentration, HBCD stock solutions in dimethyl sulfoxide (DMSO) were sonicated for at least 15 min. All other chemicals, unless otherwise stated, were obtained from Sigma-Aldrich, Zwijndrecht, The Netherlands. PC12 cell culture. Rat pheochromocytoma (PC12) cells (Greene and Tischler, 1976) were cultured in RPMI 1640 (Invitrogen, Breda, The Netherlands) supplemented with 5% fetal calf serum and 10% horse serum (ICN Biomedicals, Zoetermeer, The Netherlands). For Ca 2þ imaging experiments, undifferentiated PC12 cells were subcultured in poly-L-lysine coated glass-bottom dishes (MatTek, Ashland, MA) as described previously (Dingemans et al., 2007) . For amperometric recordings, cells were differentiated for 3-5 days with 5lM dexamethasone to enhance vesicular catecholamine release as described previously (Westerink and Vijverberg, 2002) .
Cell viability assay. Effects of HBCD on cell viability were determined by measuring the capacity of undifferentiated PC12 cells to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to formazan (Denizot and Lang, 1986) . One day before the cell viability test, PC12 cells were seeded in a 96-wells plate at a density of 5 3 10 4 cells per well. The cells were exposed to different concentrations of HBCD for 30 min, after which the cells were incubated for 30 min in 200 ll MTT (1 mg/ml) in serum-free medium. After washing the cells with phosphate buffered saline, the formazan was extracted in 100 ll of isopropanol. This isopropanol fraction was measured spectrophotometrically at 595 nm (FLUOstar Galaxy V4.30-0, BMG Labtechnologies, Offenburg, Germany) to determine the quantity of the blue formazan, which is used as a measure for cell viability. -sensitive fluorescent ratio dye Fura-2 as described previously (Dingemans et al., 2007) . Briefly, cells were loaded with 5lM Fura-2 AM (Molecular Probes; Invitrogen) in external saline (containing in mM: 1.8 CaCl 2 , 24 glucose, 10 HEPES, 5.5 KCl, 0.8 MgCl 2 , 125 NaCl, and 36.5 sucrose at pH 7.3, adjusted with NaOH) for 20 min at room temperature, followed by 15-min de-esterification in external saline. After deesterification, cells were placed on the stage of an Axiovert 35M inverted microscope (Zeiss, Gö ttingen, Germany) equipped with a TILL Photonics Polychrome IV (TILL Photonics GmBH, Gräfelfing, Germany). Fluorescence evoked by 340-and 380-nm excitation wavelengths (F 340 and F 380 ) was collected every 12 s at 510 nm with an Image SensiCam digital camera (TILL Photonics GmBH). The digital camera and polychromator were controlled by imaging software (TILLvisION, version 4.01), which was also used for data collection and processing. Changes in F 340 /F 380 ratio (R), reflecting changes in [Ca 2þ ] i , were analyzed using custom-made MS-Excel macros. Following 5-min baseline recording, cells were exposed to DMSO, HBCD (0.2-20lM), or a-, b-, or c-HBCD (0.2-2lM). Membrane depolarization by 100mM K þ was used to investigate effects of HBCD on the depolarization-evoked increase in [Ca 2þ ] i , caused by influx of Ca 2þ through VGCCs. Maximum and minimum ratios (R max and R min ) were determined after the recording by addition of ionomycin (5lM) and ethylenediamine tetraacetic acid (EDTA; 17mM) as a control for experimental conditions. Free cytosolic [Ca 2þ ] i was calculated using Grynkiewicz's equation [Ca 2þ Deitmer and Schild, 2000) , where K d* is the dissociation constant of Fura-2 determined in the experimental set-up used for the fluorescence measurements using Fura-2 Ca 2þ imaging calibration buffers (Molecular Probes; Invitrogen).
Because the standard deviation during baseline [Ca 2þ ] i recording ranged ] i observed during depolarization was used to investigate possible effects of HBCD on the depolarization-induced increase in [Ca 2þ ] i . The involvement of specific VGCCs was investigated by selective pharmacological blocking using 2lM nifedipine (L-type VGCCs), 2lM x-conotoxin GVIA (N-type VGCCs; Biotrend, Wangen, Switzerland), and 2lM x-conotoxin MVIIC (P/Q-type VGCCs; Biotrend).
Amperometry. Amperometric recordings of spontaneous and K
þ -evoked vesicular catecholamine release from dexamethasone-differentiated PC12 cells using carbon fiber microelectrodes were made as described previously (Dingemans et al., 2007; Westerink and Vijverberg, 2002 ). Following 150 s of baseline recording, PC12 cells were superfused for 15 s with high K þ -containing saline (K þ increased to 125mM and Na þ lowered to 5.5mM) to determine their responsiveness. Cells were allowed to recover for 135 s prior to a 20-min exposure to HBCD to investigate acute effects on vesicular catecholamine release. Recordings were performed at room temperature. As described previously (Dingemans et al., 2007 (Dingemans et al., , 2008 , PC12 cells with high basal release (> 2 events/min), low evoked release (< 20 events/min) or poor recovery after depolarization (''recovered basal release''; > 14 events/min) were excluded from data analysis (5/34 cells). The remaining 29 cells were used to investigate effects of HBCD on the frequency of vesicular catecholamine release and vesicular release parameters, that is, amplitude, t 1/2 (half-width) and time integral (Q, vesicular content) of the amperometric release events.
Data analysis and statistics. All data are presented as mean ± SEM from the number of cells indicated. Statistical analyses were performed using SPSS 12.0.1 (SPSS, Chicago, IL). Continuous data were compared using Student's t-test, paired or unpaired where applicable. ANOVA and post hoc t-tests were performed to investigate possible dose-response relationships. Categorical data were compared using Fisher's exact tests. A p value < 0.05 is considered statistically significant; n.s. indicates the absence of a statistically significant effect.
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RESULTS
Cell Viability
PC12 cells, cultured in a 96-wells plate, were exposed to 0-20lM technical HBCD mixture or the individual stereoisomers for 30 min before incubation in 1 mg/ml MTT. Exposure to 0-2lM HBCD (30 min) had no effects on cell viability, whereas exposure to 20lM HBCD (30 min) resulted in a limited reduction of cell viability to 88 ± 3% of control (p < 0.05). After 30 min exposure to 0-20lM a-, b-, or c-HBCD, no effects on cell viability were observed (Fig. 1) .
To investigate whether HBCD affects basal [Ca 2þ ] i , Fura-2 loaded PC12 cells were exposed for 20 min to ] i (20lM HBCD: 35%; n.s.) were not affected by exposure to HBCD (Fig. 2) . The amplitude and duration of these spontaneous fluctuations in [Ca 2þ ] i were also not affected during exposure to 20lM HBCD (data not shown). Exposure to the separate a-, b-, or c-stereoisomers (0-2lM) did neither affect the average basal [Ca 2þ ] i nor the percentage of cells showing spontaneous fluctuations in [Ca 2þ ] i , during exposure (data not shown). VGCCs expressed in undifferentiated PC12 cells include L-, N-, P/Q-, R-, and T-type Ca 2þ channels (Del Toro et al., 2003; Greene and Tischler, 1976; Liu et al., 1996; Shafer and Atchison, 1991) , with L-, N-, and P/Q-type VGCCs accounting for the majority of the depolarization-induced increase in [Ca 2þ ] i (blocking L-, N-, and P/Q-type VGCCs reduced the depolarization-evoked increase in [Ca 2þ ] i to~15% of control, data not shown). To investigate whether HBCD has an effect on the depolarization-evoked increase in [Ca 2þ ] i , PC12 cells were exposed to different concentrations of HBCD before and during depolarization by a high K þ -containing saline. When applying 20lM HBCD immediately before the depolarization, no effects were observed on the depolarization-evoked increase in [Ca 2þ ] i , making direct effects of HBCD on VGCCs less likely. When the exposure time is prolonged, the inhibitory effect on the depolarization-evoked increase in [Ca 2þ ] i aggravated. Increasing the exposure time from 20 to 40 min did not further reduce the depolarizationevoked increase in [Ca 2þ ] i (data not shown). Therefore, in all following [Ca 2þ ] i measurements, cells were exposed to HBCD for 20 min prior to depolarization.
Exposing PC12 cells for 20 min to HBCD technical mixture (0-20lM) caused a dose-dependent reduction of the subsequent depolarization-evoked increase in [Ca 2þ ] i (ANOVA: p < 0.0001; Fig. 2 ] i to 0.61 ± 0.08lM (n ¼ 57; p < 0.0001), which is approximately 40% of the control value.
Although the technical mixture mainly consists of c-HBCD, it has been observed that in biotic samples, a-HBCD is most abundant. To investigate possible differences in activity between the different stereoisomers of HBCD, PC12 cells were exposed to 2lM of the different stereoisomers (a-, b-, and c-HBCD). All three stereoisomers inhibited the depolarizationevoked increase in [Ca 2þ ] i . The inhibitory effects of a-and b-HBCD were comparable with that of the technical mixture (HBCD mixture: 1.15 ± 0.08lM; a-HBCD: 0.97 ± 0.10lM, n ¼ 36; b-HBCD: 1.16 ± 0.13lM, n ¼ 38), whereas the inhibitory effect of c-HBCD was larger (0.73 ± 0.06lM, n ¼ 58; Fig. 2 ).
To investigate whether specific VGCCs were involved in the inhibitory effects of HBCD on the depolarization-evoked increase in [Ca 2þ ] i , L-, N-, or P/Q-type VGCCs were pharmacologically blocked using 2lM of, respectively, nifedipine, GVIA, or MVIIC x-conotoxins (Fig. 3) . Though all VGCC blockers decreased the depolarization-induced increase in [Ca 2þ ] i , nifedipine had the largest effect (0.80 ± 0.05lM). Exposure to HBCD (20lM) while blocking L-type VGCCs with nifedipine, resulted in a further decrease of the depolarization-induced [Ca 2þ ] i (0.64 ± 0.07lM). Comparable results were seen when blocking either N-or P/Q-type VGCCs (Fig. 3) .
Vesicular Neurotransmitter Release
To investigate whether the observed robust reduction in depolarization-evoked [Ca 2þ ] i after exposure to 20lM HBCD has functional consequences for neurotransmitter release, FIG. 1 . Exposure of PC12 cells to the technical HBCD mixture has a small effect on cell viability only at 20lM, whereas no significant effects were observed after exposure to the individual stereoisomers. Bars represent average cell viability as measured by mitochondrial MTT reduction, normalized to DMSO control wells per plate. Bars display data from four experiments, number of wells used for data analysis: control: n ¼ 36; all HBCD treatments: n ¼ 12. *p < 0.05.
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depolarization-evoked release of catecholamines was measured following 20-min exposure to 20lM HBCD. Analysis of the release frequencies showed that the average basal release frequency amounted to 0.4 ± 0.1 events/min (n ¼ 29). Upon depolarization the release frequency increased to 97 ± 12 events/min (n ¼ 29), which slowly declined to basal release levels (recovered basal release: 2.5 ± 0.5 events/min, n ¼ 29) after cessation of depolarization. Basal release during exposure to 20lM HBCD (1.1 ± 0.3 events/min, n ¼ 14) did not significantly differ from basal release in control cells (0.5 ± 0.1 events/min, n ¼ 15; Fig. 4) . However, following 20 min exposure to HBCD,~70% of the cells (10 out of 14) no longer showed evoked release (> 20 events/min), whereas in control experiments,~85% of the cells (13 out of 15) still showed evoked release following 20-min exposure to 0.1% DMSO (p < 0.01). Release frequencies of the four cells that still show evoked release following exposure to HBCD were within the range of evoked release in control cells (20-216 events/min) and the vesicular release parameters (i.e., vesicle content, amplitude and t 1/2 ) were unaffected (data not shown).
DISCUSSION
The results presented here demonstrate that the BFR HBCD does not affect the basal [Ca 2þ ] i , which is in accordance with previous observations in rat cerebellar granule cells (Reistad et al., 2006) . Additionally, HBCD exposure does not affect the frequency of basal catecholamine release (Fig. 4) or the parameters of the vesicular release events. However, HBCD exposure does exert an inhibitory effect on the depolarizationevoked increase in [Ca 2þ ] i via VGCCs with a LOEL of 2lM (Figs. 2 and 3) as well as on depolarization-evoked vesicular catecholamine release (Fig. 4) . 
FIG. 3. HBCD a-specifically inhibits Ca
2þ influx through all major VGCC-types in PC12 cells. Nifedipine (Nif; 2lM), x-conotoxin GVIA (2lM), and x-conotoxin MVIIC (2lM) were used to block L-, N-, and P/Q-type VGCCs, respectively. All treatments significantly differ from the DMSO control. Coexposure to HBCD (20lM) results in a further reduction of the depolarization-evoked increase in [Ca 2þ ] i compared with the corresponding ''blocker alone'' treatments. Bars display data from 4 to 13 experiments per treatment. The number of cells used for data analysis is indicated inside each bar. *p < 0.05; ***p < 0.001.
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A small cytotoxic effect (measured via mitochondrial activity) was observed after exposing PC12 cells to 20lM technical HBCD mixture for only 30 min, whereas exposure to the individual stereoisomers or lower concentrations of HBCD did not result in reduction of cell viability (Fig. 1) . In cerebellar granule cells, 24 h exposure to 10lM HBCD resulted in~90% cell death, whereas 24 h exposure to 2lM HBCD (the LOEL in the current study) caused~35% cell death (Reistad et al., 2006) . A recent study (Zhang et al., 2008a) describes stereoisomer-and enantiomer-specific cytotoxicity of HBCD in HepG2 cells, showing that c-HBCD has the strongest cytotoxic effect, and that (þ)-enantiomers are significantly more toxic than the corresponding (À)-enantiomers. From the current cell viability results and other cell viability studies it can be concluded that the LOEL for effects in Ca 2þ homeostasis in the current study (2lM HBCD) is not confounded by cytotoxicity.
To investigate whether HBCD specifically blocks one subtype of VGCCs, the depolarization-induced increase in [Ca 2þ ] i was investigated in the presence of specific blockers of the different VGCC-subtypes. Though all VGCC blockers decrease the depolarization-induced increase in [Ca 2þ ] i , nifedipine has the largest effect indicating that L-type VGCCs are the most abundant VGCC-subtype in undifferentiated PC12 cells. If HBCD would specifically block one subtype of VGCCs, a combined exposure to HBCD and a specific blocker should inhibit the depolarization-induced increase in [Ca 2þ ] i to a similar extent as the specific blocker alone. A further decrease of the depolarization-induced [Ca 2þ ] i was observed after exposure to HBCD (20lM) while blocking either the L-, N-, or P/Q-type VGCCs (Fig. 3) . These combined data therefore indicate that the effect of HBCD is not VGCC-specific. Additionally, effects on other Ca 2þ -influx pathways involved in the depolarization-evoked increase in [Ca 2þ ] i cannot be excluded.
Exposing the PC12 cells to HBCD immediately before depolarization did not affect the depolarization-evoked increase in [Ca 2þ ] i . Hence, HBCD apparently has no direct effect on the VGCCs. Interestingly, the inhibitory effect of HBCD aggravates when the exposure is prolonged. The maximal effect is reached after 20 min of exposure and increasing the exposure time to 40 min did not further increase the inhibitory effect of HBCD. Although the underlying cause of the exposure-time dependency of the inhibitory effect of HBCD remains as yet unclear, a possible explanation could be the targeting of voltage-independent intracellular signaling pathways by HBCD which need some minutes to take effect. VGCCs are regulated by a range of signal transduction pathways, including phosphorylation and G-protein modulation. Nevertheless, few signaling pathways inhibit L-, N-, and P/Q-type VGCCs, and potentiation has been observed as well (for review, Westerink 2006) . Another possible explanation could reside in the physico-chemical properties of HBCD. The high n-octanolwater-partition coefficient (log K ow % 5; Hayward et al., 2006) indicates the potential for HBCD to accumulate in cell membranes. Possibly, the inhibitory effect of HBCD depends on the amount of HBCD partitioned into the cell membrane, and is limited (as the effect no longer aggravated after 20 min exposure) by the available quantity of HBCD and the absolute quantity of cell membrane. If so, effects on other membraneanchored proteins, including ion channels, cannot be excluded.
The percentage of cells that do not show evoked release following HBCD exposure is significantly increased. However, cells that still exhibit depolarization-evoked release following HBCD exposure display a release frequency that is comparable to control cells, suggesting that the inhibition of the depolarization-evoked release is related to the inhibition of depolarization-evoked increase in [Ca 2þ ] i , whereas exocytosis and its underlying processes appear unaffected. Thus, due to the inhibition of the depolarization-evoked [Ca 2þ ] i a larger proportion of the cells probably does not reach the Ca 2þ threshold for release after exposure to HBCD.
HBCD has previously been shown to inhibit the plasma membrane uptake of dopamine (IC 50 : 4lM, measured after 15 min exposure to HBCD), as well as the vesicular uptake of dopamine (IC 50 : 3lM, measured after 15 min exposure to HBCD; Mariussen and Fonnum, 2003) . Inhibition of uptake of dopamine in rat brain synaptic vesicles has also been demonstrated for the commercial penta-PBDE mixture DE-71 and ortho-PCBs (for review, Mariussen and Fonnum, 2006) . However, changes in vesicle content were not observed following exposure to HBCD. This indicates that the functional consequences for quantal release per se are rather limited, or are obscured because of the relatively short time span of the amperometric experiments compared with the slow rate of vesicle cycling in PC12 cells (Westerink et al., 2000) .
Human HBCD serum levels are based on only a few observations, which so far have been limited to European countries and the United States. HBCD intake related to oily fish consumption was estimated to be 0.3 ng/kg bw/day (Knutsen et al., 2008) . The highest concentration of HBCD measured in human serum in an occupational setting (856 ng/g lipids; Thomsen et al., 2007) corresponds to~15nM HBCD in blood (calculated using average physiologic values), which is approximately two orders of magnitude lower than the LOEL in this study. For risk assessment this difference is relatively small, especially considering safety factors for species extrapolation and intraspecies variability, as well as the lipophilic and bioaccumulative properties of HBCD. Considering the current findings on neuronal signaling, additional safety regulations in an occupational setting should be considered.
The highest background level of HBCD measured in humans is 7.4 ng/g lipids (Meijer et al., 2008) , which corresponds tõ 0.13nM HBCD in blood (calculated using average physiologic values). This is approximately four orders of magnitude lower than the LOEL in this study, thus well below the concentrations at which adverse effects have been observed. Nevertheless, in vivo HBCD exposure is expected to be of a longer or maybe even lifelong duration, whereas the LOEL obtained in this in vitro study was based on only 20-min exposure. Additional concern arises from the fact that organohalogen compounds, including PCBs, PBDEs and HBCD, transfer across the placenta (Meijer et al., 2008) . Also, HBCD has been detected in human breast milk, up to 5 ng/g lipids (Antignac et al., 2008) . As it has been shown that exposure to HBCD within the time frame of rapid brain development results in behavioral defects in mice (Eriksson et al., 2006) , it is concerning that children are exposed to HBCD pre-as well as postnatally.
The major constituent of the technical mixture, c-HBCD, has a larger effect on the depolarization-evoked increase in [Ca 2þ ] i than a-and b-HBCD, which have a comparable effect as seen with the technical mixture. Presently, very few toxicity data is available to compare the activity of the three stereoisomers present in the technical HBCD mixture. All three stereoisomers affect the thyroid hormone system, but c-HBCD to the largest extent (Palace et al., 2008) . Nevertheless, biotic samples are generally dominated by a-HBCD (Covaci et al., 2006) , although for humans this has been demonstrated only once (Antignac et al., 2008) . This shortage in knowledge on the potency of the individual stereoisomers and (tissue-specific) stereoisomer distribution in humans hampers proper effect and risk assessment. In this light it is noteworthy that as a-HBCD is less potent but more common in biological samples, neurotoxic effects might be overestimated when the technical mixture, which mostly contains c-HBCD, is used in experimental studies. In view of the differences observed in response between the individual stereoisomers, future toxicity studies should include these stereoisomers to improve the relevance of experimental studies for the human exposure situation.
The cessation of the use of the penta-and octa-PBDE, and in the EU also the use of the deca-BDE, could result in increased use of HBCD in polystyrene materials as an alternative for the banned PBDEs. Consequently, it is not unlikely that human exposure levels increase in the future. Considering this potential increase as well as the current findings on neuroendocrine functioning, additional efforts to establish an adequate exposure, hazard, and risk assessment are justified.
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